Here’s what you should know:
1. The FDA wants probiotic manufacturers to specify the amount of live microbials in colony-forming units.
2. Manufacturers aren’t currently required to report CFUs.
3. The AGA believes all manufacturers should voluntarily do so.
4. The AGA also believes the FDA could go further and expand the amount of information manufacturers are required to report. The AGA recommends including storage conditions and expiration dates.
5. The society said in a press release, “We acknowledge that researchers are evaluating other methods and units of measure besides CFUs for not only live microbials but also microbial bioactivity. However, in the absence of a widely accepted alternative, which may take several years to develop and adopt, AGA strongly encourages FDA and manufacturers to take the small step forward of using CFUs now rather than waiting for another solution to emerge.”
More articles on gastroenterology:
Texas Digestive Disease Consultants finds PE partner, forms GI practice management company
10 ASC developments costing $10M+ — October 2018
Turkey attacks, in-law mishaps & more: 20 ICD-10 codes to know for Thanksgiving
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
